Torii Pharmaceutical Co., Ltd.

TSE:4551.T

4140 (JPY) • At close November 5, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q12012 Q42012 Q32012 Q22012 Q12011 Q42011 Q32011 Q22011 Q12010 Q42010 Q32010 Q22010 Q12009 Q42009 Q32009 Q22009 Q12008 Q42008 Q3
Revenue 15,02414,85813,45115,50613,43313,88811,81113,57912,21312,14210,96013,55011,88211,6569,89911,52710,31510,2869,57111,67710,63611,5239,16117,00714,99216,62113,93018,40815,63616,48213,60816,43814,75515,27313,74017,53615,40716,13613,29814,50112,35514,58415,66613,91113,94711,76514,36912,91213,24611,08313,60812,24911,77610,86212,03111,06311,3789,34311,60410,72010,7488,29610,2899,283
Cost of Revenue 8,2328,2147,4878,7497,3287,4826,2887,1226,3456,3765,6736,4585,6985,6974,7955,4135,0715,0284,4495,8575,0615,3924,3928,2977,7118,8826,9548,6917,8297,9716,8028,4297,7027,6806,4758,7097,9457,7616,3986,7325,7026,8097,2836,0156,1595,2696,3695,4995,7034,9275,6535,1244,8344,6324,8814,4604,6293,7424,2983,9334,0103,1143,5673,412
Gross Profit 6,7926,6445,9646,7576,1056,4065,5236,4575,8685,7665,2877,0926,1845,9595,1046,1145,2445,2585,1225,8205,5756,1314,7698,7107,2817,7396,9769,7177,8078,5116,8068,0097,0537,5937,2658,8277,4628,3756,9007,7696,6537,7758,3837,8967,7886,4968,0007,4137,5436,1567,9557,1256,9426,2307,1506,6036,7495,6017,3066,7876,7385,1826,7225,871
Gross Profit Ratio 0.4520.4470.4430.4360.4540.4610.4680.4760.480.4750.4820.5230.520.5110.5160.530.5080.5110.5350.4980.5240.5320.5210.5120.4860.4660.5010.5280.4990.5160.50.4870.4780.4970.5290.5030.4840.5190.5190.5360.5380.5330.5350.5680.5580.5520.5570.5740.5690.5550.5850.5820.590.5740.5940.5970.5930.5990.630.6330.6270.6250.6530.632
Reseach & Development Expenses 8338315326793983562,057572506407176321180223108139176224573687548489861,0371,0471,0381,0161,0921,2941,0701,1521,0771,5399961,0421,5701,3171,2311,1191,1131,1411,4781,9321,5971,6551,9862,1521,8361,8501,0518191,7799824,341693548411435399328449479250206
General & Administrative Expenses 03,6913,7143,83200000000000000000000000-56757127550-57056562507-57959355510551583-5225355352,858-5285075071,902-5265204872,8355045094972,8564655124921,849482511
Selling & Marketing Expenses 03643344213883963775303983453081,3969909838181,0908896776608876646656171,5191,2401,2701,1451,5311,1711,3381,0511,4511,1951,2711,0861,5411,2201,3321,0541,0648301,0441,0401,0858739869859668261,0861,0621,1668651,0429409918068849771,009813845908867
SG&A 4,4404,0554,0484,2533883963775303983453081,3969909838181,0908896776608876646656171,5191,2401,2701,1451,5311,1711,3381,0511,4511,1951,2711,0861,5411,2201,3321,0541,0648301,0441,0401,0858733,3199859668262,9885361,6861,3523,8771,4441,5001,3033,7401,4421,5211,3052,6941,3901,378
Other Expenses 05-24553,5243,8813,5813,6233,508581254881516632136692810812184428101713983211136155116-18281019234-1201241167204
Operating Expenses 5,2734,8864,5804,9324,4054,4585,9584,9834,4854,3753,9925,5904,8184,8604,4114,9284,4273,7723,8685,0505,2045,1325,4756,8036,3476,3976,2057,0956,5196,6736,2696,7646,6956,5606,0787,4026,4316,6566,1536,1365,9646,7746,9976,6176,4636,8606,9266,4536,41412,4413,5274,5793,47211,5823,2723,1312,8177,5822,9662,9162,8427,2002,7102,633
Operating Income 1,5191,7581,3841,8251,7011,947-4371,4741,3841,3901,2921,5031,3651,0996891,1858151,4861,252768372999-7091,9079351,3407692,6211,2891,8385331,2453571,0331,1841,4251,0331,7167451,6346851,0011,3851,2801,321-3651,0729611,126-6,2854,4282,5463,470-5,3423,9433,5033,992-1,9264,4133,9213,960-6,9055,6303,238
Operating Income Ratio 0.1010.1180.1030.1180.1270.14-0.0370.1090.1130.1140.1180.1110.1150.0940.070.1030.0790.1440.1310.0660.0350.087-0.0770.1120.0620.0810.0550.1420.0820.1120.0390.0760.0240.0680.0860.0810.0670.1060.0560.1130.0550.0690.0880.0920.095-0.0310.0750.0740.085-0.5670.3250.2080.295-0.4920.3280.3170.351-0.2060.380.3660.368-0.8320.5470.349
Total Other Income Expenses Net 17358-22445671-2321436619-46734038-404552-66656-24010-4,15640,656-1,98641420383216611564332526040-948-32931372933479253716,571-1,264-2,092-2,3202,347-2,119-2,209-2,2772,429-2,166-2,101-2,1917,236-3,129-2,107
Income Before Tax 1,6921,8161,1602,2811,7721,945-4051,6171,4501,4091,2461,5761,4051,1376491,2308678201,308528382-3,15739,947-799761,3447892,6591,3211,8545391,3604211,0661,2091,6851,0731,7077931,3057161,0381,4141,3131,368-3561,0741,0141,1972863,1644541,150-2,9951,8241,2941,7155032,2471,8201,7693312,5011,131
Income Before Tax Ratio 0.1130.1220.0860.1470.1320.14-0.0340.1190.1190.1160.1140.1160.1180.0980.0660.1070.0840.080.1370.0450.036-0.2744.361-0.0050.0650.0810.0570.1440.0840.1120.040.0830.0290.070.0880.0960.070.1060.060.090.0580.0710.090.0940.098-0.030.0750.0790.090.0260.2330.0370.098-0.2760.1520.1170.1510.0540.1940.170.1650.040.2430.122
Income Tax Expense 388474281529491569-116529439446364439411329213243159-118445-372110-82911,4241,00427736422071331048215027514938740548837560726050028064599565553-3134654175101551,644198446-1,0817195167451799757717711671,111451
Net Income 1,3041,3438781,7511,2821,374-2891,0881,0119638821,136994808436987708938862901272-2,32828,522-1,0847009795691,9471,0101,3733881,0842726808031,1966991,100532806435974816747815-436095976861321,520256703-1,9151,1047779703241,2721,0489971631,390680
Net Income Ratio 0.0870.090.0650.1130.0950.099-0.0240.080.0830.0790.080.0840.0840.0690.0440.0860.0690.0910.090.0770.026-0.2023.113-0.0640.0470.0590.0410.1060.0650.0830.0290.0660.0180.0450.0580.0680.0450.0680.040.0560.0350.0670.0520.0540.058-0.0040.0420.0460.0520.0120.1120.0210.06-0.1760.0920.070.0850.0350.110.0980.0930.020.1350.073
EPS 46.3947.7831.2462.345.6148.89-10.2938.729.398.9531.410.8135.3928.7715.5335.1425.2133.4130.7432.19.69-82.961,016.43-38.6324.9534.920.2969.4236.0148.9513.8538.659.724.0328.3942.2624.738.8718.8328.4815.434.4228.8326.428.82-1.5221.5221.0924.264.6653.719.0524.87-67.6639.0127.4534.2711.4544.9437.0335.225.7649.1124.02
EPS Diluted 46.3947.7831.2462.345.6148.89-10.2938.729.398.9531.410.5735.3928.7715.5335.1425.2133.4130.7332.19.69-82.961,016.43-38.6324.9534.920.2969.4236.0148.9513.8538.659.724.0328.3942.2624.738.8718.8328.4815.434.4228.8326.428.82-1.5221.5221.0924.264.6653.719.0524.87-67.6639.0127.4534.2711.4544.9437.0335.225.7649.1124.02
EBITDA 1,7901,8521,4901,9461,7811,955-3851,6341,4641,2361,2651,6051,4211,2086711,2598501,5861,3168514351,062-6571,9469721,3717892,6691,3221,8575551,2864231,0671,2231,4691,1241,7487931,6627191,0261,4151,3151,368-3611,0741,0161,222-6,260767,0143,509-4,9854,2983,8524,325-1,5414,7734,2644,281-6,4615,9725,425
EBITDA Ratio 0.1190.1250.1110.1250.1330.141-0.0330.120.120.1020.1150.1180.120.1040.0680.1090.0820.1540.1370.0730.0410.092-0.0720.1140.0650.0820.0570.1450.0850.1130.0410.0780.0290.070.0890.0840.0730.1080.060.1150.0580.070.090.0950.098-0.0310.0750.0790.092-0.5650.0060.5730.298-0.4590.3570.3480.38-0.1650.4110.3980.398-0.7790.580.584